However, as time frames are less likely known, I'm forced to give the one that is mot likely to require the more time the annual period, resulting in the remaining three becoming the Q's.
Therefore
2019 Tip MNS
Magnis Technologies hold the world class battery grade graphite mine, Nachua, in Tanzania, which will eventually feed the three battery factories they are building: New York; Germany; Townsville. All three appear to be proceeding, with NY being the most advanced and will begin 1 GW production this year, to be eventually stepped up to 15GW.
The important aspect of their batteries is that they are cobalt and nickel free, so that if you have been following the battery development story, you'll realise that this will lead to some great advantages on different fronts.
Nachua, like all Tanzanian mining has suffered from governmental 'interference' in recent years, although this seems to have recently changed, and Nachua will come out on top of all the foreign owned mines there will the sole export licence. One indicator of things heating up there, is the conversion of options by the Tanzanian manager at $.40, when the share price was about .30, costing
>$300k. Furhermore, a very heavy hitting Director has stepped up to run operations overall.
MNS will require the full year to put back on the gains it had previously earned, but I'm predicting the present prices, to be the low, due to the above mentioned events, and therefore well suiting this comp.
2019 tips Q: PO3; AIY; BGT
As mentioned above, I'd prefer more time than a Q for all these to play out, but MNS definitely requires that extra time, so it has been given the annual spot. But these remaining three are not without reasonable probability of earlier success, particularly PO3 and AIY, although the later will require the Q financials to prove its case, resulting in further gains possibly being outside this comp period.
PO3 - Puriploh is the third largest riser of ASX stocks this year, with much more to go. It's recent dramatic rise began when Bill Parfeit, a US billionaire, bought $9.8 M worth at $2.40 when the price was 50 cents, an ASX all record premium. PO3 uses a disruptive technology FRG (free radical generation) in water, air, and surface sterilization to eliminate pathogens. The scope of applications are limitless, and the present rial in an Indian hospital to eradicate TB will provide the necessary results for a Q gain. Results in 2nd half January.
AIY - Authorized Investment Fund is an ASX-listed Pooled Development Fund, meaning no capital gains are required by investors. They have a range of investments, mostly in SE Asia, and the two most recent developments are the most exciting, both likely to bring excellent returns.
They own 25% (+5%) of AIM, an elite slow and electronic publication of all goods expensive, catering to the travel industry and rich and famous market. Most recently, they have launched Travel Elite: in China:
“The growth in the outbound travel market from China has been astonishing but it has been extremely difficult for advertisers to reach this audience at a time when they are planning and booking their trips. Travel Elite will solve this problem for advertisers and enable them to promote using highly targeted sites at a time when they have just planned and booked a trip on an outbound carrier. For luxury brands, duty free products and the tourism industry this provides a unique and unrivalled opportunity”. “The response to Travel Elite China has been instant and unprecedented “ “Within hours of launching Travel Elite China to a handful of our clients, we received requests for campaign proposals well in excess of US $2.0 million. “The launch of and response to Travel Elite China has resulted unprecedented interest in the product and has exceeded our expectations in every way”. “At this pace we are set for astonishing returns which will ensure considerable additional revenues building substantial and solid capital growth for both Ambient, Aim and its shareholders”
Aenea cosmetics in their most recent investment, which is an upper market epigenetics cosmetic range very popular with the R & F, and they hold many exclusive rights in the best stores world-wide. https://www.authorisedinvestment.com.au/
BGT - 'Biogene is an Australian agtech development company enabling the next generation of novel insecticides to address the global problems of insecticide resistance and toxicity. Its novel platform technology is based on a naturally occurring class of chemicals known as beta-triketones. Beta-triketone compounds have demonstrated insecticidal activity (e.g. kill or knock down insects) via a novel mode of action in testing performed to date. This platform may provide multiple potential new solutions for insecticide manufacturers in applications across animal health and crop protection, as well as in public health, and in consumer applications. The Company’s aim is to develop and commercialise a broad portfolio of targeted insect control and management solutions.'
When biogene and their first major contract, likelihood being sometime this year, it shod really put it on the global map. https://bio-gene.com.au/
(20min delay)
